Utah Medical Products, Inc.UTMDNASDAQ
Loading
EBITDA Over TimeStable
Percentile Rank14
3Y CAGR-14.7%
5Y CAGR-4.4%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
-14.7%/yr
vs +5.5%/yr prior
5Y CAGR
-4.4%/yr
Recent deceleration
Acceleration
-20.2pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthStable
PeriodValueYoY Change
TTM$16.68M+1.5%
2024$16.44M-33.6%
2023$24.75M-7.9%
2022$26.87M+2.7%
2021$26.16M+25.1%
2020$20.92M-14.7%
2019$24.51M+13.2%
2018$21.65M-0.6%
2017$21.78M+14.5%
2016$19.02M-